These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38022020)

  • 1. Neurological Manifestations of Connective Tissue Disorders.
    Poshattiwar RS; Acharya S; Shukla S; Kumar S
    Cureus; 2023 Oct; 15(10):e47108. PubMed ID: 38022020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connective tissue disorders: systemic lupus erythematosus, Sjögren's syndrome, and scleroderma.
    Streifler JY; Molad Y
    Handb Clin Neurol; 2014; 119():463-73. PubMed ID: 24365313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLE Neuropathy-Anything New?
    Londhey VA
    J Assoc Physicians India; 2015 Dec; 63(12):11-12. PubMed ID: 27666897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supporting the differential diagnosis of connective tissue diseases with neurological involvement by blood and cerebrospinal fluid flow cytometry.
    Heming M; Müller-Miny L; Rolfes L; Schulte-Mecklenbeck A; Brix TJ; Varghese J; Pawlitzki M; Pavenstädt H; Kriegel MA; Gross CC; Wiendl H; Meyer Zu Hörste G
    J Neuroinflammation; 2023 Feb; 20(1):46. PubMed ID: 36823602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).
    Bodolay E; Csiki Z; Szekanecz Z; Ben T; Kiss E; Zeher M; Szücs G; Dankó K; Szegedi G
    Clin Exp Rheumatol; 2003; 21(3):313-20. PubMed ID: 12846049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
    Cansu DÜ; Korkmaz C
    Clin Rheumatol; 2023 Oct; 42(10):2601-2610. PubMed ID: 36396789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroinflammation in systemic lupus erythematosus - a review.
    Bărbulescu AL; Sandu RE; Vreju AF; Ciurea PL; Criveanu C; Firulescu SC; Chisălău AB; Pârvănescu CD; Ciobanu DA; Radu M; Pădureanu V; Boldeanu MV; Albu VC
    Rom J Morphol Embryol; 2019; 60(3):781-786. PubMed ID: 31912087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of Neurological Manifestations of SARS-CoV-2.
    Priyal ; Sehgal V; Kapila S; Taneja R; Mehmi P; Gulati N
    Cureus; 2023 Apr; 15(4):e38194. PubMed ID: 37257164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological manifestations of systemic lupus erythematosus: a prospective study.
    Wong KL; Woo EK; Yu YL; Wong RW
    Q J Med; 1991 Oct; 81(294):857-70. PubMed ID: 1801058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological syndromes in systemic lupus erythematosus and their association with antiphospholipid syndrome.
    Honczarenko K; Budzianowska A; Ostanek L
    Neurol Neurochir Pol; 2008; 42(6):513-7. PubMed ID: 19235104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological Complications in Patients with Systemic Lupus Erythematosus.
    Shaban A; Leira EC
    Curr Neurol Neurosci Rep; 2019 Nov; 19(12):97. PubMed ID: 31773306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric Involvement in Juvenile-Onset Systemic Lupus Erythematosus.
    Khajezadeh MA; Zamani G; Moazzami B; Nagahi Z; Mousavi-Torshizi M; Ziaee V
    Neurol Res Int; 2018; 2018():2548142. PubMed ID: 30002929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India.
    Pradhan V; Patwardhan M; Rajadhyaksha A; Dhawale N; Ghosh K
    Rheumatol Int; 2015 Mar; 35(3):541-5. PubMed ID: 25119833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric manifestations and their attribution to systemic lupus erythematosus: a retrospective single-center study in a Polish population.
    Pawlak-Buś K; Schmidt W; Leszczyński P
    Pol Arch Intern Med; 2022 Nov; 132(11):. PubMed ID: 35984958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indscators of blood lipid profile, acute phase reactions and uric acid in patients with arterial hypertension combined with connective tissue dysplasia.
    Zaremba YH; Rak NO; Zaremba OV; Zaremba-Fedchyshyn OV; Virna MM; Odnorih LO
    Wiad Lek; 2018; 71(2 pt 1):356-360. PubMed ID: 29729173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lupus Cerebritis as a Rare Neuropsychiatric Manifestation of Systemic Lupus Erythematosus.
    Leitao AR; Jain MS; Luvsannyam E; Jayswal V; Tiesenga F
    Cureus; 2022 May; 14(5):e24973. PubMed ID: 35698669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.